Kinase inhibitors: the road ahead

FM Ferguson, NS Gray - Nature reviews Drug discovery, 2018 - nature.com
Receptor tyrosine kinase signalling pathways have been successfully targeted to inhibit
proliferation and angiogenesis for cancer therapy. However, kinase deregulation has been …

Ribosomal protein S6: a potential therapeutic target against cancer?

YW Yi, KS You, JS Park, SG Lee, YS Seong - International journal of …, 2021 - mdpi.com
Ribosomal protein S6 (RPS6) is a component of the 40S small ribosomal subunit and
participates in the control of mRNA translation. Additionally, phospho (p)-RPS6 has been …

Phase-separation mechanism for C-terminal hyperphosphorylation of RNA polymerase II

H Lu, D Yu, AS Hansen, S Ganguly, R Liu, A Heckert… - Nature, 2018 - nature.com
Hyperphosphorylation of the C-terminal domain (CTD) of the RPB1 subunit of human RNA
polymerase (Pol) II is essential for transcriptional elongation and mRNA processing,–. The …

The pol II CTD: new twists in the tail

J Zaborowska, S Egloff, S Murphy - Nature structural & molecular …, 2016 - nature.com
The C-terminal domain (CTD) of the large subunit of RNA polymerase (pol) II comprises
conserved heptad repeats, and post-translational modification of the CTD regulates …

Regulation of muscle stem cell functions: a focus on the p38 MAPK signaling pathway

J Segalés, E Perdiguero… - Frontiers in cell and …, 2016 - frontiersin.org
Formation of skeletal muscle fibers (myogenesis) during development and after tissue injury
in the adult constitutes an excellent paradigm to investigate the mechanisms whereby …

Modification of histidine repeat proteins by inorganic polyphosphate

N Neville, K Lehotsky, Z Yang, KA Klupt, A Denoncourt… - Cell Reports, 2023 - cell.com
Inorganic polyphosphate (polyP) is a linear polymer of orthophosphate that is present in
nearly all organisms studied to date. A remarkable function of polyP involves its attachment …

DYRK1A and cognition: A lifelong relationship

ML Arbones, A Thomazeau… - Pharmacology & …, 2019 - Elsevier
The dosage of the serine threonine kinase DYRK1A is critical in the central nervous system
(CNS) during development and aging. This review analyzes the functions of this kinase by …

Genome-scale high-resolution mapping of activating and repressive nucleotides in regulatory regions

J Ernst, A Melnikov, X Zhang, L Wang, P Rogov… - Nature …, 2016 - nature.com
Massively parallel reporter assays (MPRAs) enable nucleotide-resolution dissection of
transcriptional regulatory regions, such as enhancers, but only few regions at a time. Here …

DYRK1A regulates B cell acute lymphoblastic leukemia through phosphorylation of FOXO1 and STAT3

RS Bhansali, M Rammohan, P Lee… - The Journal of …, 2021 - Am Soc Clin Investig
DYRK1A is a serine/threonine kinase encoded on human chromosome 21 (HSA21) that has
been implicated in several pathologies of Down syndrome (DS), including cognitive deficits …

DYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development in Down Syndrome

A Duchon, Y Herault - Frontiers in behavioral neuroscience, 2016 - frontiersin.org
Down syndrome (DS) is one of the leading causes of intellectual disability, and patients with
DS face various health issues, including learning and memory deficits, congenital heart …